Spectrum and prevalence ofBRCA1 andBRCA2 germline mutations in Sardinian patients with breast carcinoma through hospital-based screening (Q57781606)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16047344%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

title

Spectrum and prevalence of BRCA1 and BRCA2 germline mutations in Sardinian patients with breast carcinoma through hospital-based screening (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16047344%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16047344%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Marina Pisano

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16047344%20AND%20SRC:MED&resulttype=core&format=json

Antonio Giuseppe Maria Cossu

4 January 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16047344%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Giuseppe Palmieri

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16047344%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

author name string

Mario Budroni

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16047344%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Antonio Farris

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16047344%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Antonio Contu

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16047344%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Paola Baldinu

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16047344%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Francesco Tanda

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16047344%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Maria F Dedola

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16047344%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

language of work or name

English

0 references

publication date

1 September 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16047344%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

number of pages

8

1 reference

inferred from page(s)

published in

Cancer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16047344%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

volume

104

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16047344%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16047344%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

page(s)

1172-1179

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16047344%20AND%20SRC:MED&resulttype=core&format=json

The genetic attributable risk of breast and ovarian cancer

4 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21298

7 January 2021

Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21298

7 January 2021

Variation in cancer risks, by mutation position, in BRCA2 mutation carriers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21298

7 January 2021

Cancer risks in BRCA2 mutation carriers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21298

7 January 2021

The breast cancer information core: database design, structure, and scope

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21298

7 January 2021

Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21298

7 January 2021

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21298

7 January 2021

Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21298

7 January 2021

A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21298

7 January 2021

Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21298

7 January 2021

Genome-wide scanning for linkage in Finnish breast cancer families

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21298

7 January 2021

Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21298

7 January 2021

BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21298

7 January 2021

Large regional differences in the frequency of distinct BRCA1/BRCA2 mutations in 517 Dutch breast and/or ovarian cancer families

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21298

7 January 2021

BRCA 1/2 gene mutation testing-based cancer prevention and the moral concerns of different types of patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21298

7 January 2021

Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21298

7 January 2021

Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21298

7 January 2021

Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21298

7 January 2021

BRCA1 and BRCA2 germline mutations in Sardinian breast cancer families and their implications for genetic counseling

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21298

7 January 2021

Identification of a founder BRCA2 mutation in Sardinia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21298

7 January 2021

Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21298

7 January 2021

Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21298

7 January 2021

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21298

7 January 2021

Frequency of BRCA1/BRCA2 mutations in a population-based sample of young breast carcinoma cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21298

7 January 2021

Differential Contributions ofBRCA1andBRCA2to Early-Onset Breast Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21298

7 January 2021

Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Anglian Breast Cancer Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21298

7 January 2021

Prevalence of BRCA1 in a hospital-based population of Dutch breast cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21298

7 January 2021

Population-Based Study of BRCA1 and BRCA2 Mutations in 1035 Unselected Finnish Breast Cancer Patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21298

7 January 2021

Population-based study of risk of breast cancer in carriers of BRCA2 mutation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21298

7 January 2021

Prevalence of recurring BRCA mutations among Ashkenazi Jewish women with breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21298

7 January 2021

FounderBRCA1 andBRCA2 mutations in early-onset French Canadian breast cancer cases unselected for family history

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21298

7 January 2021

The Jewish Ashkenazi founder mutations in the BRCA1/BRCA2 genes are not found at an increased frequency in Ashkenazi patients with prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21298

7 January 2021

The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21298

7 January 2021

Screening for genomic rearrangements in families with breast and ovarian cancer identifies BRCA1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21298

7 January 2021

Identifiers

DOI

10.1002/CNCR.21298

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16047344%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference